Navigation Links
Hepatitis Rates Soar Among IV Drug Users, Study Finds

WEDNESDAY, July 27 (HealthDay News) -- About 10 million injection drug users worldwide have hepatitis C, and 1.3 million have hepatitis B, a new study reports.

Hepatitis can lead to cirrhosis, liver failure and liver cancer.

Researchers analyzed international data and found that rates of hepatitis C infection among injection drug users (IDUs) were 60 to 80 percent in 25 countries and greater than 80 percent in 12 other countries.

These countries included Spain (80 percent), Norway (76 percent), Germany (75 percent), France (74 percent), United States (73 percent), China (67 percent), Canada (64 percent), Italy (81 percent), Portugal (83 percent), Pakistan (84 percent), the Netherlands (86 percent), Thailand (90 percent) and Mexico (97 percent).

Lower rates were seen in New Zealand (52 percent), Australia (55 percent) and the United Kingdom (50 percent), the researchers noted.

The countries believed to have the largest number of IDUs infected with hepatitis C virus (HCV) are China (1.6 million), the United States (1.5 million) and Russia (1.3 million), the investigators found.

Rates of hepatitis B infection were 5 to 10 percent in 21 countries and more than 10 percent in 10 countries. The highest rates were in Vietnam (20 percent), Estonia (19 percent), Saudi Arabia (18 percent) and Taiwan (17 percent). The United Kingdom had the highest rate in Western Europe at 9 percent. The rate in the United States was 12 percent.

The study, released to coincide with World Hepatitis Day, is published online July 28 in The Lancet.

"The public-health response to blood-borne virus transmission in IDUs has mainly centered on HIV. Maintenance and strengthening of the response to HIV in IDUs remains crucial, but the significance of viral hepatitis needs to receive greater attention than it does at present," Paul Nelson, from the National Drug and Alcohol Research Centre at the University of New South Wales in Sydney, and colleagues wrote.

"Efforts to prevent, treat, and reduce harms related to liver disease in IDUs are essential -- especially in situations in which HIV has successfully been prevented or managed -- because the large numbers of IDUs infected with HCV and significant morbidity resulting from this infection mean that the health and economic costs of HCV transmitted by injected drug use might be as high as (or higher than) those of HIV," the authors added.

"Nonetheless, HCV treatment is underused. Part of the reason for this neglect is the high cost, which will remain a substantial barrier to increasing of treatment coverage in low-resource settings until costs are reduced," the researchers concluded.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about viral hepatitis.

-- Robert Preidt

SOURCE: The Lancet, news release, July 27, 2011

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. INFORMS study: OR models of hepatitis B prove decisive in treating millions in US, China
2. Hepatitis B vaccination for health care students lags behind recommendations
3. Hepatitis C is transmitted by unprotected sex between HIV-infected men
4. P7 protein resistance mutations identified; represent drug targets for hepatitis C virus
5. Stepped-up vaccine series for hepatitis B is effective during pregnancy
6. New Drug Effectively Treats Hepatitis C
7. NEJM study: New drug represents breakthrough in treatment of hepatitis C
8. Noninvasive liver tests may predict hepatitis C patient survival
9. Analysis finds mortality from all causes higher among hepatitis C-infected
10. Scientists create humanized mouse model for hepatitis C
11. Coffee drinking improves hepatitis C treatment response
Post Your Comments:
Related Image:
Hepatitis Rates Soar Among IV Drug Users, Study Finds
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, "Voices in ... that delves into an array of issues that are presently affecting Americans. Dedicated to ... dialogue, this show is changing the subjects consumers focus on, one episode at a ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... and prominent nonprofit healthcare organizations in the country. They have overseen financial turnarounds, ... and helped advance the healthcare industry as a whole through their advocacy and ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point Recovery, ... together on Thanksgiving Day to share the things that they are most grateful ... Point YouTube channel, patients displayed what they wrote on index cards, describing the ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... of workshops to discuss bioavailability and the need to integrate dose form selection ... in collaboration with OBN, the membership organization supporting and bringing together the UK’s ...
(Date:11/26/2015)... Viejo, CA (PRWEB) , ... November 26, 2015 ... ... users a new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This ... style options. These classically-influenced trailer titles work with any font, giving users limitless ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... "Radioimmunoassay Market by Type (Reagents & ... Academics, Clinical Diagnostic Labs), Application (Research, Clinical ... 2020" report to their offering. ... addition of the "Radioimmunoassay Market by ...
(Date:11/25/2015)... , Nov. 25, 2015  The American Academy ... Gynecologists (ACOG), and the March of Dimes cheered ... Protecting Our Infants Act of 2015 (S.799), ... of newborns born exposed to drugs, such as ... bill,s introduction, all three organizations have worked together ...
(Date:11/25/2015)... 25, 2015  Henry Schein, Inc., the world,s largest ... dental, medical and animal health practitioners, will unveil at ... Henry Schein ConnectDental® Pavilion , which brings together for ... solutions designed to help any practice or laboratory enter ... for a schedule of experts appearing at the Pavilion. ...
Breaking Medicine Technology: